Classically, type 1 diabetes has been viewed as a disease of the immune system present prior to dysglycemia, with autoimmune biomarkers, islet autoantibodies directed against insulin and, other beta cell proteins [1]. This evidence concerns the gene INS and type 1 diabetes mellitus.